“Venom: The Last Dance” has kicked off its cinematic journey with a robust $124 million at the international box office, providing a solid cushion to offset its slower domestic performance. While Tom Hardy’s third and final outing as the alien symbiote may not have lit up North America, it still marks a significant opening that fans of the franchise can celebrate.
Strong International Debut, Mixed Domestic Reception
The latest entry in Sony’s Marvel spinoff series debuted with $51 million in North America, bringing its global total to a commendable $175 million. Internationally, this launch ranks as the third largest Hollywood opening of 2024, trailing only behind Disney’s “Inside Out 2” and the highly anticipated “Deadpool & Wolverine.”
Despite its $120 million production budget—excluding promotional costs—“Venom: The Last Dance” needs to maintain momentum internationally to justify its expenses. Given that theater owners typically retain about 50% of ticket sales, the film’s performance outside the U.S. is crucial. For context, the original “Venom” soared to $856 million globally, while its sequel, “Let There Be Carnage,” earned over $500 million.
International Highlights and Key Markets
Opening in 64 markets across 53,700 screens, “Venom: The Last Dance” has seen impressive results, particularly in China, where it grossed $46 million over its first five days—making it the biggest superhero movie debut in the country since 2019’s “Spider-Man: Far From Home.” Other notable markets included:
- Mexico: $7.3 million
- South Korea: $5.8 million
- United Kingdom: $5.7 million
- India: $4.7 million
These strong international numbers bode well for the film’s continued success.
What Else is Shaking in the Box Office?
In addition to “Venom: The Last Dance,” other films are making waves in the international box office. “The Wild Robot,” an animated adventure from Universal and DreamWorks, added $17.5 million from 79 markets, bringing its overseas total to $120.9 million and a global gross of $232 million.
Meanwhile, Paramount’s horror sequel “Smile 2” continues to perform steadily, generating $12.6 million from 67 territories in its second weekend. The follow-up to the 2022 hit has amassed $43 million overseas and a total of $83.7 million worldwide against a budget of $28 million.
Conclusion: Venom’s Journey Continues
As “Venom: The Last Dance” navigates its path through theaters, fans are eager to see how it performs in the coming weeks. With strong international numbers, it may still find its footing despite a quieter reception at home. As audiences flock to see Hardy’s final performance as Venom, the film’s journey is just beginning, and the franchise’s future remains tantalizingly open.
This dynamic entry into the Marvel universe showcases the power of international audiences in determining a film’s fate, reminding us all that the world of cinema is ever-evolving and full of surprises.
